Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 27 clinical trials
None
TranspulmonarY Estrogen Gradient and Estrogen Receptors (TYEGER) in PAH

and clot formation -- making the vessels less capable of gas exchange. Currently, PAH therapies focus on dilating the "good" remaining vessels that haven't been altered by this disease process

hpah
vascular disease
hypertension
right heart catheterization
pulmonary arterial pressure
  • 0 views
  • 30 Jan, 2021
  • 1 location
None
Hyperbaric Oxygen Therapy for Hemorrhagic Cystitis Post HSCT

hemorrhage, leading to clot formation within the urinary tract and even renal failure. This complication results in much pain to the patient and increasing treatment cost. Late-onset HC (two weeks

antiviral agents
acute graft-versus-host disease
clot formation
tissue damage
hemorrhagic cystitis
  • 1 views
  • 18 Sep, 2021
  • 1 location
None
Effects of Perampanel on Neurophysiology Test Perimeters

This is a study to evaluate the effects of perampanel, a FDA approved drug for epilepsy, on commonly performed neurophysiology tests: electroencephalogram (EEG), somatosensory evoked potential (SEP), brainstem auditory evoked potential (BAEP), and visual evoked potential (VEP). Many other drugs used in the treatment of epilepsy have been shown to …

  • 18 views
  • 28 Aug, 2021
  • 1 location
None
PREvention of STroke in Intracerebral haemorrhaGE Survivors With Atrial Fibrillation

fibrillation (AF) who have recently had a bleeding in their brain, (ICH). This is a trial where half of the participants will take an anticoagulant medication, preventing blood clot formation, and half will

anticoagulants
clot
brain imaging
apixaban oral tablet
vascular disease
  • 16 views
  • 25 Feb, 2021
  • 28 locations
None
Peri-Procedural Myocardial Infarction Platelet Reactivity Thrombin Generation and Clot Strength: Differential Effects of Eptifibatide + Bivalirudin Versus Bivalirudin

The purpose of this study is to compare levels of clot formation (platelet aggregation), markers of heart muscle damage, and inflammation in two groups undergoing percutaneous coronary

platelet aggregation
clot
infarct
myocardial infarction
bivalirudin
  • 6 views
  • 07 Nov, 2020
  • 1 location
None
Low INR to Minimize Bleeding With Mechanical Valves Trial

target will decrease the risk of bleeding or increase the risk of blood clot formation and stroke. These results have the potential to reduce the burden of bleeding in patients with a mechanical heart

  • 0 views
  • 19 Nov, 2021
  • 4 locations
None
Pre-operative Enoxaparin in the Surgical Management of Multi-trauma Patients Undergoing Orthopedic Surgical Procedures

surgery as well as preventing deep vein clot formation. This will be a randomized double blinded study using Lovenox or placebo as the medications given preoperatively. Postoperative Lovenox will be given

enoxaparin
lovenox
clot
  • 0 views
  • 25 Oct, 2021
  • 1 location
None
Prehospital Transfusion Strategy in Bleeding Patients

shock (expressed as base deficit). Endothelial function and ability of clot formation is preserved to a greater extent in patients receiving plasma.

red blood cell transfusion
clot
  • 0 views
  • 18 Oct, 2021
None
A Genomic Approach for Clopidogrel in Caribbean Hispanics

Clopidogrel is a prescription medicine used to minimize blood clot formation in patients with cardiovascular disease, particularly those undergoing heart catheterization and stroke. A

cardiovascular disease
antiplatelet therapy
clot
dapt
clopidogrel
  • 106 views
  • 15 Oct, 2021
  • 2 locations
None
Haemophilia and Bone Loss - PHILEOS Study

clot formation, causing excessive bleeding (mainly haemarthrosis). Osteoporosis is a systemic bone disease characterized by a low bone mineral density (BMD). A decrease of mean BMD has been described

thrombin
clot
clot formation
osteoporosis
antihemophilic factor
  • 15 views
  • 11 Apr, 2021
  • 19 locations